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ng author.
esses: dr_rampal1@hotSummary Study design: A cross-sectional study was conducted in all states of
Malaysia to determine the prevalence, awareness, treatment and control of
hypertension. A stratified two-stage cluster sampling design with proportional
allocation was used.
Methods: Trained nurses obtained two blood pressure measurements from each
subject. Hypertension was defined as mean systolic blood pressure 4140mmHg,
diastolic blood pressure490mmHg, or a self-reported diagnosis of hypertension and
taking antihypertensive medication. All data were analysed using Stata 9.2 software
and took the complex survey design into account. A two-sided P-value of o0.05 was
considered to be statistically significant.
Results: The overall prevalence of hypertension for subjects aged X15 years was
27.8% (95% confidence interval (CI) 26.9–28.8). The prevalence of hypertension was
significantly higher in males (29.6%, 95% CI 28.3–31.0) compared with females
(26.0%, 95% CI 25.0–27.1). Multivariate logistic regression showed that the odds of
having hypertension increased with increasing age, in males, in subjects with a
family history of hypertension, with increasing body mass index, in non-smokers and
with decreasing levels of education. Only 34.6% of the subjects with hypertension
were aware of their hypertensive status, and 32.4 were taking antihypertensive
medication. Amongst the latter group, only 26.8% had their blood pressure under
control. The prevalence of hypertension amongst those aged X30 years has
increased from 32.9% in 1996 to 40.5% in 2004.
Conclusion: In Malaysia, the prevalence of hypertension is high, but levels of
awareness, treatment and control are low. There is an urgent need for aThe Royal Institute of Public Health. Published by Elsevier Ltd. All rights reserved.
mail.com, rampal@medic.upm.edu.my (L. Rampal).
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L. Rampal et al.12comprehensive integrated population-based intervention programme to ameliorate
the growing problem of hypertension in Malaysians.
& 2007 The Royal Institute of Public Health. Published by Elsevier Ltd. All rights
reserved.Introduction
Cardiovascular disease (CVD) is responsible for 30%
of all deaths worldwide.1,2 It remains the most
common cause of death in industrialized countries,
and hypertension is the most common treatable
risk factor.3 The prevalence of hypertension has
been widely reported in various regions of the
world.4,5 Hypertension is an important public
health problem worldwide because of its high
prevalence and its detrimental sequelae.6,7 It is
ranked third as a cause of disability-adjusted life-
years and is a leading risk factor for mortality.8
Hypertension is as prevalent in many developing
countries as in the developed world.9 By 2025, 1.56
billion people are expected to have hypertension
(29% of the world’s adult population).10 Approxi-
mately 7.1 million deaths per year may be
attributed to hypertension.11 Large population-
based cohort studies consistently show continuous,
strong and graded relationships between blood
pressure (particularly systolic pressure) and the
subsequent occurrence of various atherosclerotic
events.12,13 Multiple long-term cohort studies
and randomized clinical trials have shown that
the risks from raised blood pressure can be partially
reversed.14,15 National surveys on prevalence,
awareness, treatment and control of hypertension
guide health policy makers in devising and
reviewing strategies towards better control of
blood pressure in the population. The aim of
this study was to describe the prevalence, aware-
ness, treatment and control of hypertension in
Malaysia.Method
Study location, study design and study
population
Geographically, this study covered the whole of
Malaysia, i.e. peninsular Malaysia and the states of
Sabah and Sarawak in east Malaysia. This study had
a population-based cross-sectional design. Malay-
sian residents aged X15 years were included in this
study.Sampling method, recruitment of subjects
and data collection
Sampling was undertaken by the Statistics Depart-
ment of Malaysia using a stratified two-stage
cluster sampling design with proportional alloca-
tion. Each state and the Federal Territory of Kuala
Lumpur constituted a primary stratum. The whole
country was divided into artificially created, con-
tiguous geographical areas called ‘enumeration
blocks’ (EBs). An EB consisted of 80–120 living
quarters (LQs) and had specified boundaries (either
natural or artificial) that did not straddle adminis-
trative boundaries. Allocation of sample size for
the study within the EBs was based on the number
of LQs in the stratum. Approximately, eight LQs
were selected from a sampled EB, with the actual
number being determined by the size of the EB
based on the latest listing exercise of the Statistics
Department of Malaysia. In total, 8510 LQs were
sampled from the selected EBs. The Ethical
Committees of the Ministry of Health Malaysia and
the Faculty of Medicine and Health Science,
Universiti Putra Malaysia approved the study.Data collection
The first step was for a public health worker to
locate the houses included in the sample in their
respective districts. When an LQ (house) included
in the sample was found to be vacant, the house on
the immediate right was selected instead. An
appointment was arranged with the head of the
selected household who was informed of the
study’s objectives by the public health worker.
When the occupants of the sampled household
were not present at the time of the initial visit,
repeat visits was made either by appointment or by
leaving messages with the neighbours. Visits to the
LQs were then made by a trained interviewer at the
appointed date. After giving their verbal consent,
all respondents aged X15 years were interviewed
by trained interviewers using a structured pre-
tested questionnaire. The information given was
transcribed immediately to the questionnaire.
Information on age, sex, ethnicity, smoking
status, history and family history of hypertension,
use of antihypertensive medications and education
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dized questionnaire. A qualified nurse measured
blood pressure manually using a mercury sphygmo-
manometer. The study protocol procedures (includ-
ing measurement of blood pressure) were reviewed
with the staff and the nurses in a meeting before
the study commenced. This meeting was held
with the aim of preparation of fieldwork, logistic
support and to reduce interobserver variability in
the measurements. The instrument was also
calibrated regularly. Two blood pressure measure-
ments were obtained for all subjects in a sitting
position in their respective residence. The average
of these two readings was used to classify an
individual.
Weight was measured using a digital bathroom
scale (TANITA Model HD 309), calibrated before use.
Height was measured using a SECA Body Meter
Model 208. Specific quality checks were made to
ensure the quality of the data collected. Body mass
index (BMI) was calculated as weight in kilograms
divided by the square of height in metres. The
subjects were classified in terms of nutritional
status based on the World Health Organization’s
recommendation.
A 10-day training period was conducted centrally
for the interviewers. The main aims of the training
programme were to develop the interviewers’
interpersonal communication and interviewing
skills, familiarize them with the questionnaires,
motivate them, and improve team-building skills.
Random checking for completeness of interviews
was conducted on a daily basis.
Definitions
Hypertension
Hypertension was defined as a systolic blood
pressure of X140mmHg and/or a diastolic blood
pressure of X90mmHg on two readings, or a self-
reported diagnosis of hypertension and taking anti-
hypertensive medication.
Blood pressure control
Blood pressure control was defined as a mean blood
pressure of o140/90mmHg.
Statistical analysis
This study was designed to provide national
estimates of the prevalence of hypertension
amongst those aged X15 years in Malaysia. All
data were analysed using Stata 9.2 software and
took the complex survey design into account.16
Post-stratification adjustment of weights was per-formed, taking into account the differences in sex,
ethnicity and age distribution between the sample
and the total Malaysian population. Categorical
variables were presented as percentages with 95%
CI, and any differences in proportions were tested
using an adjusted Chi-squared test. Continuous
variables were presented as means with 95% CI.
Multiple logistic regression was used to investigate
the relationship between the prevalence of hyper-
tension and age, sex, ethnicity, family history of
hypertension, education status, current smoking
status and nutritional status. From the model-
building process, urban status was not significant
and was removed from the final model. The chunk
test revealed no significant first-order interactions.
A two-sided P-value of o0.05 was considered to be
statistically significant.Results
Characteristics of respondents by age, sex
and ethnicity
Of the 8510 LQs sampled, 7927 (93.2%) were
represented in this study. Table 1 shows the
characteristics of the respondents by age, sex and
ethnicity. Blood pressure measurements were
recorded for 16,440 out of 18,805 respondents
aged X15 years, giving a response rate of 87.4%.
The majority of the respondents were Malays
(56.0%), followed by Chinese (20.3%) and Indians
(10.6%). Most (57.6%) of the respondents were
females. The age-, sex- and ethnicity-adjusted
weighted mean age of the respondents was 36.7
years (95% CI 36.3–37.1) and ranged from 15 to 100
years. There was no significant difference between
the mean age of males (36.6 years) and the mean
age of females (36.8 years) ðP ¼ 0:38Þ.
Prevalence of hypertension by age and sex
Table 2 shows the prevalence of hypertension by
age and sex. The results show that the prevalence
of hypertension in respondents aged X15 years was
27.8% (95% CI 26.9–28.8).
The results show that the prevalence of hyper-
tension increases with age in both sexes. For
Malaysians aged 15–39 years, hypertension was
significantly more prevalent in males than females
(Po0.05). However, the prevalence of hyperten-
sion in males and females was not significantly
different above the age of 40 years. Further
analysis carried out to compare these results
with other studies showed that the standardized
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Table 2 Prevalence of hypertension by age and sex amongst Malaysians aged X15 years.
Age (years) Sex, % (95% CI) P-value
Men Female Both sexes
Age standardized, X15 29.6 (28.3–31.0) 26.0 (25.0–27.1) 27.8 (26.9–28.8) o0.001
Age standardized, X20 33.4 (31.8–34.8) 29.9 (28.7–31.1) 31.6 (30.5–32.7)
Age standardized, X30 41.5 (39.7–43.3) 39.6 (38.1–41.1) 40.5 (39.3–41.8)
Age standardized, X40 50.9 (49.0–52.9) 52.1 (50.3–53.8) 51.5 (50.1–52.9)
15–19 9.2 (7.1–11.3) 4.1 (2.5–5.7) 6.7 (5.4–8.0)
20–29 13.9 (11.8–16.1) 6.4 (5.1–7.7) 10.2 (8.9–11.4)
30–39 23.4 (20.9–26.1) 16.0 (14.1–18.0) 19.7 (18.1–21.4)
40–49 38.5 (35.6–41.4) 36.6 (34.2–39.1) 37.6 (35.6–39.5)
50–59 56.7 (53.4–60.0) 57.3 (54.3–60.3) 57.0 (54.8–59.3)
X60 66.5 (63.4–69.5) 71.8 (69.0–74.6) 69.3 (67.1–71.5)
CI, confidence interval.
Table 1 Characteristics of respondents by age, sex and ethnicity.
Characteristics of respondents Frequency (n ¼ 2219) Unweighted percentage Weighted percentage
Sex
Male 6979 42.4 50.1
Female 9461 57.6 49.9
Total 16 440 100.0 100.0
Age group (years)
15–19 2187 13.3 15.2
20–29 2963 18.0 24.9
30–39 3172 19.3 20.6
40–49 3196 19.4 17.5
50–59 2463 15.0 11.5
X60 2459 15.0 10.2
Ethnicity
Malay 9214 56.0 53.6
Chinese 3333 20.3 27.0
Indian 1735 10.6 8.2
Others 196 1.2 0.6
Sarawak Bumiputra 675 4.1 4.6
Sabah Bumiputra 1287 7.8 6.1
Weighted percentage—age, sex and ethnicity standardized to the Malaysian population 2004.
L. Rampal et al.14prevalence of hypertension for respondents aged
X30 years was 40.5% (95% CI 39.3–41.8). The
overall mean systolic blood pressure was 122mmHg
(95% CI 122–122) and the overall mean diastolic
blood pressure was 79mmHg (95% CI 79–79). The
mean systolic blood pressure for males (124mmHg,
95% CI 123–124) was significantly higher than that
for females (121mmHg, 95% CI 121–122). Similarly,
the mean diastolic blood pressure for males
(80mmHg, 95% CI 80–81) was significantly higher
than that for females (78mmHg, 95% CI 78–78).Prevalence of hypertension by age and
ethnicity
Table 3 shows that the prevalence of hypertension
increased with age in all ethnic groups. For those
respondents aged X15 years, the Chinese had the
highest prevalence of hypertension (30.6%), fol-
lowed by the Malays (26.7%) and the Indians
(25.1%). The indigenous people from the state of
Sarawak ‘Sarawak Bumiputra’ had a higher pre-
valence of hypertension (31.1%) compared with the
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Table 3 Prevalence of hypertension by age among the main ethnic groups aged X15 years in Malaysia in 2004.
Age (years) Ethnic groups, % (95% CI)
Malay Chinese Indians Sarawak Bumiputra Sabah Bumiputra
X15 26.7 (25.6–28.0) 30.6 (28.5–32.6) 25.1 (23.0–27.1) 31.1 (26.4–35.7) 25.6 (22.7–28.6)
Female 26.3 (25.0–27.6) 27.3 (25.0–29.7) 22.4 (19.6–25.2) 26.4 (21.0–31.8) 22.9 (19.4–26.5)
Male 27.2 (25.6–28.9) 33.7 (30.7–36.7) 27.7 (24.4–31.0) 35.7 (29.8–41.7) 28.2 (23.8–32.5)
X30 41.3 (39.6–42.9) 40.0 (37.4–42.5) 37.7 (34.5–41.0) 40.4 (34.7–46.1) 41.3 (37.5–45.1)
15–19 6.0 (4.5–7.6) 8.4 (4.7–12.1) 6.4 (2.5–10.3) 14.0 (5.3–22.7) 5.4 (1.5–9.4)
20–29 9.6 (8.0–11.2) 10.7 (7.6–13.8) 9.0 (5.1–12.9) 14.4 (8.8–19.9) 9.7 (6.1–13.3)
30–39 21.0 (18.9–23.2) 14.2 (11.7–17.5) 15.1 (10.4–19.7) 26.7 (19.6–33.7) 32.4 (26.7–38.1)
40–49 38.1 (35.5–40.7) 35.2 (31.3–39.2) 37.8 (32.1–43.4) 45.3 (36.2–54.3) 37.5 (31.0–44.0)
50–59 59.2 (56.4–62.1) 55.0 (50.5–59.5) 53.9 (47.2–60.6) 49.1 (38.6–59.7 58.7 (50–67.4)
X60 67.6 (64.6–70.5) 71.1 (67.1–75.0) 73.2 (66.8–79.6) 64.5 (55.0–74.1) 67.0 (58.7–75.3)
CI, confidence interval.
Table 4 Prevalence of awareness, treatment and control of hypertension by sex amongst Malaysians aged X15
years in 2004.
Sex, % (95% CI) P-value
Male Female Both sexes
Hypertensives
Aware 29.4 (27.4–31.5) 40.6 (38.5–42.7) 34.6 (33.1–36.2) o0.001
Treated 27.3 (25.4–29.4) 38.1 (36.0–40.2) 32.4 (30.9–33.9) o0.001
Controlled 7.4 (6.3–8.5) 10.0 (8.8–11.4) 8.6 (7.8–9.5) 0.001
Treated hypertensives
Controlled 26.9 (23.4–30.7) 26.3 (23.4–29.3) 26.6 (24.2–29.0) 0.781
CI, confidence interval.
Prevalence, awareness, treatment and control of hypertension in Malaysia 15other ethnic groups. Further analysis undertaken
for comparison with other studies showed that the
prevalence of hypertension in those aged 430
years is very high. Malays and the indigenous people
from the state of Sabah ‘Sabah Bumiputra’ had the
highest prevalence estimates (41.3%) followed by
the ‘Sarawak Bumiputra’ (40.4%), the Chinese
(40.0%) and the Indians (37.7%). These differences
in estimates were not significantly significant
ðP ¼ 0:72Þ.Awareness, treatment and control of
hypertension
Table 4 shows that only 34.6% (95% CI 33.1–36.2) of
the study subjects with hypertension were aware
that they had hypertension. Females were signifi-
cantly more aware of their hypertensive status
(40.6%) compared with males (29.4%), and were
more likely to be on treatment and have their
blood pressure under control (Po0.01). Amongthose classified as hypertensive, 32.4% (95% CI
30.9–33.9) were taking antihypertensive medica-
tion. Among those taking hypertensive medication,
only 26.6% (95% CI 24.2–29.0) had a blood pressure
of p140/90mmHg. Blood pressure control was only
achieved in 8.6% (95% CI 7.8–9.5) of the respon-
dents who had hypertension.Relationship between hypertension and age,
sex, family history, BMI, smoking status and
education level
In the logistic regression analysis with prevalence
of hypertension as the dependent variable, there
was a significant crude association with age, sex,
family history, BMI and education (Table 5). Using
the final multivariate logistic regression model, the
adjusted odds (aOR) of hypertension prevalence
increased as age increased. The aOR of a male
having hypertension was 70% higher than that for a
female. Obese individuals (BMI X30) were eight
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Table 5 Relationship between hypertension and sex, family history of hypertension and body mass index.
Risk factor Crude odds ratio (95% CI) Adjusted odds ratio (95% CI)
Age groups (years)
15–19 1.0 1.0
20–29 1.6 (1.2–2.0) 1.3 (1.03–1.7)
30–39 3.4 (2.7–4.3) 2.4 (1.9–3.1)
40–49 8.4 (6.6–10.6) 5.5 (4.3–7.0)
50–59 18.5 (14.7–23.2) 11.5 (9.0–14.8)
X60 31.4 (24.9–39.5) 22.5 (17.6–28.9)
Male 1.2 (1.1–1.29) 1.7 (1.6–2.0)
Ethnicity
Malay 1.0 1.0
Chinese 1.2 (1.1–1.3) 1.0 (0.9–1.2)
Indian 0.9 (0.8–1.0) 0.9 (0.8–1.0)
Sarawak Bumiputra 1.2 (0.9–1.5) 1.3 (1.0–1.8)
Sabah Bumiputra 0.9 (0.8–1.1) 1.3 (1.03–1.5)
Family history of hypertension 1.6 (1.5–1.7) 1.8 (1.6–2.0)
Body mass index
o18.5 1.0 1.0
18.5 to o25 2.6 (2.1–3.1) 2.0 (1.6–2.5)
25 to o30 6.4 (5.3–7.7) 4.5 (3.6–5.6)
X30 9.7 (7.9–11.9) 8.1 (6.3–10.3)
Non-smoker 1.1 (1.0–1.2) 1.3 (1.1–1.5)
Highest education attained
X13 years (tertiary) 1.0 1.0
7–12 years (secondary) 1.4 (1.2–1.6) 1.3 (1.1–1.5)
1–6 years (primary) 4.8 (4.0–5.7) 1.8 (1.5–2.2)
No formal education 7.3 (6.0–8.8) 2.1 (1.7–2.7)
CI, confidence interval.
L. Rampal et al.16times more likely to have hypertension than
individuals with a BMI o18.5 (aOR 8.1, 95% CI
6.3–10.3). Individuals with a family history of
hypertension were twice as likely to have hyper-
tension than those without a family history of
hypertension (aOR 1.8, 95% CI 1.6–2.0). A non-
smoker was 1.3 times more likely to have hyperten-
sion compared with a smoker (aOR 1.3, 95% CI
1.1–1.5). The prevalence of hypertension was
negatively associated with different education
levels. Compared with subjects with a tertiary
education, the likelihood of having hypertension
was highest amongst those with no formal educa-
tion (aOR 2.1, 95% CI 1.7–2.7).Discussion
CVD has been the leading cause of death in Malaysia
for the last 40 years. The relationship between
blood pressure and the risk of CVD events iscontinuous, consistent and independent of
other risk factors. The higher the blood pressure,
the greater the risk of heart attack, heart failure,
stroke and kidney disease. The presence of addi-
tional risk factors such as smoking, diabetes
and high cholesterol levels increases the CVD risk
from hypertension.17,18 In Malaysia, this is com-
pounded by the fact that the prevalence of
current smokers for Malaysians aged X15 years is
44.6% for males and 2.5% for females.19 This study
provides evidence of the increasing burden of
disease due to hypertension, and that current
detection and treatment of hypertension is inade-
quate in Malaysia. The last National Health and
Morbidity Survey (NHMS) in Malaysia was carried
out in 1996,20 and reported the prevalence of
hypertension to be 32.9% amongst respondents
aged X30 years. The present study used the same
methods for blood pressure measurement as the
NHMS in 1996, and found that the prevalence of
hypertension in the same group had risen to 40.5%
in 2004.
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hypertension were aware of their hypertensive
status, only 32.4% had ever been treated, and only
8.6% had their blood pressure under control (o140/
90mmHg). Comparatively, in 1996, 33% were aware
of their hypertensive status, 31% had ever been
treated, and only 6% had their blood pressure under
control. This shows that Malaysia still has a serious
problem with low awareness, low treatment and
poor control of hypertension, and CVD remains the
leading cause of death.
Burt et al. reported that the prevalence of
hypertension in the adult US population declined
progressively between 1971 and 1991, and the
distributions of systolic and diastolic blood pressure
have shifted downwards. Awareness, treatment
and control of hypertension among the adult US
population have also improved tremendously,
accounting for much of the shift at the upper end
of the distribution.21 This study concurs with the
NHMS in Malaysia in 1996 that women were more
aware of their hypertensive status and more likely
to be treated.
In this study, the prevalence of hypertension
increased with age in both sexes. Interestingly, the
prevalence estimates of hypertension were higher
in males compared with females for those aged
o50 years. For those aged X50 years, the
prevalence estimates of hypertension were higher
among females. The effect of oestrogen on blood
pressure is still controversial.22 Endogenous oestro-
gen from the female gonads lowers blood pressure
by stimulating endogenous vasodilators and inhibit-
ing endogenous vasoconstrictors. However, there is
evidence that exogenous oestrogen increases
rather than decreases blood pressure. Post-meno-
pausal women have lower endogenous oestrogen,
which may explain the increase in the prevalence
of hypertension post-menopausally. However, as for
exogenous oestrogen, post-menopausal women
experience a supraphysiological concentration of
oestrogen in the liver. This leads to stimulation of
the renin–angiotensin system via increased produc-
tion of angiotensinogen in the liver. Therefore, it is
not the levels of oestrogen alone that determine
blood pressure levels.
The NHMS in 1996 did not report an ethnic
breakdown of the prevalence of hypertension.
Although the different races (Malays, Chinese and
Indians) have been living in Malaysia for more than
50 years, for those respondents aged X30 years,
there was a difference in the estimated prevalence
of hypertension between the different ethnic
groups, but these differences were not statistically
significant. The differences in prevalence between
ethnic groups may be attributed to their geneticmake-up and/or different socio-environmental fac-
tors. The current transition of diseases in Malaysia
may be affecting the ethnic groups differently. The
explanation is most likely to be an interaction
between genetic and environmental factors. There
is evidence from Malaysia to show that Malays may
have increased beta adrenergic receptor sensitivity
compared with Chinese and Indians.23 There is also
evidence that Malays have different genotype
frequency to angiotensin receptor polymorphism
than other races.24
The China Multicentre Study of Cardiovascular
Epidemiology of 1998 reported a national preva-
lence of 24%.25 While the rate of blood pressure
control reported in this study showed that it had
improved (from 12.7% to 19.9%), the rate remains
low. Population studies on secular trends of
hypertension have generally shown disappointing
results. Even in the USA, there was a period of
worrying trends concerning awareness, treatment
and control of hypertension.26
The projection by Kearney et al.27 is of concern,
especially for the developing world. Hypertension
is projected to pose a serious public health
challenge well into 2025, with most of the socio-
economic burden to be shouldered by the develop-
ing world. While global rates of blood pressure
control are generally poor, the situation is worse in
developing countries.28 Although 24-h blood pres-
sure measurements are useful to evaluate the
differences between day and night and to exclude
the ‘white-coat’ effect, this could not be carried
out in this study because of practical constraints.
Furthermore, most population-based studies on
hypertension use a similar methodology. Informa-
tion about diet and salt intake was not included in
this study because of time constraints and the
unavailability of a validated food frequency ques-
tionnaire.
In conclusion, the prevalence of hypertension is
high in both males and females. It poses a serious
problem with low awareness, low treatment and
poor control. As Malaysia is a country in epidemio-
logical transition, it faces the daunting prospect of
even higher prevalence in the future. A compre-
hensive programme and concerted effort needs to
be put into place if improvement is to be achieved.Acknowledgements
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